Adding evidence to the role of NEUROG1 in congenital cranial dysinnervation disorders

被引:2
|
作者
Dupont, Juliette [1 ]
Vieira, Jose Pedro [2 ]
Tavares, Ana Lisa Taylor [3 ,4 ]
Conceicao, Carla Ribeiro [5 ]
Khan, Suliman [6 ]
Bertoli-Avella, Aida Maria [6 ]
Sousa, Ana Berta [1 ,7 ]
机构
[1] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Dept Genet, Lisbon, Portugal
[2] Ctr Hosp Univ Lisboa Cent, Hosp Dona Estefania, Dept Neurol, Lisbon, Portugal
[3] Cambridge Univ Hosp NHS Fdn Trust, East Anglian Med Genet Serv, Cambridge, England
[4] Queen Mary Univ London, Dept Hlth, Genom England, Charterhouse Sq, London, England
[5] Ctr Hosp Univ Lisboa Cent, Hosp Dona Estefania, Dept Neuroradiol, Lisbon, Portugal
[6] CENTOGENE AG, Res Data Anal, Rostock, Germany
[7] Univ Lisbon, Lab Imunol Basica, Fac Med, Lisbon, Portugal
关键词
aplasia/hypoplasia of sensory cranial ganglia; congenital cranial dysinnervation disorder; NEUROG1; oromotor dysfunction; sensorineural deafness; trigeminal nerve aplasia/hypoplasia; vestibulo-cochlear nerve aplasia/hypoplasia; OKIHIRO-SYNDROME; MUTATIONS; PROTEIN; SALL4;
D O I
10.1111/cge.13922
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Congenital cranial dysinnervation disorders (CCDDs) are a heterogeneous group of neurodevelopmental phenotypes caused by a primary disturbance of innervation due to deficient, absent, or misguided cranial nerves. Although some CCDDs genes are known, several clinical phenotypes and their aetiologies remain to be elucidated. We describe a 12-year-old boy with hypotonia, developmental delay, sensorineural hearing loss, and keratoconjunctivitis due to lack of corneal reflex. He had a long expressionless face, severe oromotor dysfunction, bilateral agenesis/severe hypoplasia of the VIII nerve with marked atresia of the internal auditory canals and cochlear labyrinth malformation. Trio-exome sequencing identified a homozygous loss of function variant in the NEUROG1 gene (NM_006161.2: c.202G > T, p.Glu68*). NEUROG1 is considered a causal candidate for CCDDs based on (i) the previous report of a patient with a homozygous gene deletion and developmental delay, deafness due to absent bilateral VIII nerves, and severe oromotor dysfunction; (ii) a second patient with a homozygous NEUROG1 missense variant and corneal opacity, absent corneal reflex and intellectual disability; and (iii) the knockout mouse model phenotype which highly resembles the disorder observed in humans. Our findings support the growing compelling evidence that loss of NEUROG1 leads to a very distinctive disorder of cranial nerves development.
引用
收藏
页码:588 / 593
页数:6
相关论文
共 49 条
  • [41] Behavioural and functional evidence revealing the role of RBFOX1 variation in multiple psychiatric disorders and traits
    Aet O’Leary
    Noèlia Fernàndez-Castillo
    Gabriela Gan
    Yunbo Yang
    Anna Y. Yotova
    Thorsten M. Kranz
    Lena Grünewald
    Florian Freudenberg
    Ester Antón-Galindo
    Judit Cabana-Domínguez
    Anais Harneit
    Janina I. Schweiger
    Kristina Schwarz
    Ren Ma
    Junfang Chen
    Emanuel Schwarz
    Marcella Rietschel
    Heike Tost
    Andreas Meyer-Lindenberg
    Christiane A. Pané-Farré
    Tilo Kircher
    Alfons O. Hamm
    Demian Burguera
    Nina Roth Mota
    Barbara Franke
    Susann Schweiger
    Jennifer Winter
    Andreas Heinz
    Susanne Erk
    Nina Romanczuk-Seiferth
    Henrik Walter
    Andreas Ströhle
    Lydia Fehm
    Thomas Fydrich
    Ulrike Lueken
    Heike Weber
    Thomas Lang
    Alexander L. Gerlach
    Markus M. Nöthen
    Georg W. Alpers
    Volker Arolt
    Stephanie Witt
    Jan Richter
    Benjamin Straube
    Bru Cormand
    David A. Slattery
    Andreas Reif
    Molecular Psychiatry, 2022, 27 : 4464 - 4473
  • [42] Behavioural and functional evidence revealing the role of RBFOX1 variation in multiple psychiatric disorders and traits
    O'Leary, Aet
    Fernandez-Castillo, Noelia
    Gan, Gabriela
    Yang, Yunbo
    Yotova, Anna Y.
    Kranz, Thorsten M.
    Gruenewald, Lena
    Freudenberg, Florian
    Anton-Galindo, Ester
    Cabana-Dominguez, Judit
    Harneit, Anais
    Schweiger, Janina, I
    Schwarz, Kristina
    Ma, Ren
    Chen, Junfang
    Schwarz, Emanuel
    Rietschel, Marcella
    Tost, Heike
    Meyer-Lindenberg, Andreas
    Pane-Farre, Christiane A.
    Kircher, Tilo
    Hamm, Alfons O.
    Burguera, Demian
    Mota, Nina Roth
    Franke, Barbara
    Schweiger, Susann
    Winter, Jennifer
    Heinz, Andreas
    Erk, Susanne
    Romanczuk-Seiferth, Nina
    Walter, Henrik
    Stroehle, Andreas
    Fehm, Lydia
    Fydrich, Thomas
    Lueken, Ulrike
    Weber, Heike
    Lang, Thomas
    Gerlach, Alexander L.
    Noethen, Markus M.
    Alpers, Georg W.
    Arolt, Volker
    Witt, Stephanie
    Richter, Jan
    Straube, Benjamin
    Cormand, Bru
    Slattery, David A.
    Reif, Andreas
    MOLECULAR PSYCHIATRY, 2022, 27 (11) : 4464 - 4473
  • [43] The length of FOXE1 polyalanine tract in congenital hypothyroidism: Evidence for a pathogenic role from familial, molecular and cohort studies
    Grassi, Elisa Stellaria
    Rurale, Giuditta
    de Filippis, Tiziana
    Gentilini, Davide
    Carbone, Erika
    Coscia, Francesca
    Uraghi, Sarah
    Bullock, Martyn
    Clifton-Bligh, Roderick J.
    Gupta, Abhinav K.
    Persani, Luca
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [44] Transcriptional control by HNF-1: Emerging evidence showing its role in lipid metabolism and lipid metabolism disorders
    Liu, Fang
    Zhu, Xiao
    Jiang, Xiaping
    Li, Shan
    Lv, Yuncheng
    GENES & DISEASES, 2022, 9 (05) : 1248 - 1257
  • [45] The role of insulin/IGF1 signalling in neurodevelopmental and neuropsychiatric disorders-Evidence from human neuronal cell models
    Rethelyi, Janos M.
    Vincze, Katalin
    Schall, Dorothea
    Glennon, Jeffrey
    Berkel, Simone
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2023, 153
  • [46] Current evidence supporting a role of cannabinoid CB1 receptor (CB1R) antagonists as potential pharmacotherapies for drug abuse disorders
    Beardsley, PM
    Thomas, BF
    BEHAVIOURAL PHARMACOLOGY, 2005, 16 (5-6): : 275 - 296
  • [47] Analysis of the UPR transducer IRE1α in neurodegenerative disorders: Further evidence against a major role of ER stress in prion disease pathology
    Voigtlaender, Till
    Unterberger, Ursula
    PRION, 2012, 6 : 59 - 59
  • [48] Dysregulation of metabolic pathways by carnitine palmitoyl-transferase 1 plays a key role in central nervous system disorders: experimental evidence based on animal models
    Trabjerg, Michael Sloth
    Morkholt, Anne Skottrup
    Lichota, Jacek
    Oklinski, Michal Krystian Egelund
    Andersen, Dennis Christian
    Jonsson, Katrine
    Mork, Kasper
    Skjonnemand, Marie-Louise Nibelius
    Kroese, Lona John
    Pritchard, Colin Eliot Jason
    Huijbers, Ivo Johan
    Gazerani, Parisa
    Corthals, Angelique
    Nieland, John Dirk Vestergaard
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [49] Dysregulation of metabolic pathways by carnitine palmitoyl-transferase 1 plays a key role in central nervous system disorders: experimental evidence based on animal models
    Michael Sloth Trabjerg
    Anne Skøttrup Mørkholt
    Jacek Lichota
    Michal Krystian Egelund Oklinski
    Dennis Christian Andersen
    Katrine Jønsson
    Kasper Mørk
    Marie-Louise Nibelius Skjønnemand
    Lona John Kroese
    Colin Eliot Jason Pritchard
    Ivo Johan Huijbers
    Parisa Gazerani
    Angelique Corthals
    John Dirk Vestergaard Nieland
    Scientific Reports, 10